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ABSTRACT 
Lymphatic filariasis results in an altered lymphatic system and the abnormal enlargement of body parts, causing 
pain, serious disability and social stigma. Effective vaccines are still not available nowadays, drugs against the 
disease is required. Protein disulfide isomerase (PDI) is an essential catalyst of the endoplasmic reticulum which 
is involved in folding and chaperone activities in different biological systems. Here, we report the enzymatic 
characterization of a Brugia malayi Protein disulfide isomerase (BmPDI), which was expressed and purified 
from Escherichia coli BL21 (DE3). Western blotting analysis showed the recombinant BmPDI could be recog-
nized by anti-BmPDI Rabbit serum. The rBmPDI exhibited an optimum activity at pH 8 and 40 °C. The enzyme 
was inhibited by aurin and PDI inhibitor. Recombinant BmPDI showed interaction with recombinant Brugia 
malayi calreticulin (rBmCRT). The three-dimensional model for BmPDI and BmCRT was generated by homol-
ogy modelling. A total of 25 hydrogen bonds were found to be formed between two interfaces. There are 259 
non-bonded contacts present in the BmPDI-BmCRT complex and 12 salt bridges were formed in the interaction.  
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INTRODUCTION 
Lymphatic filariasis affects about 120 
million people worldwide (Michael et al., 
1996; Doharey et al., 2014). Several excreto-
ry and secretory (E/S) products are dis-
charged by the parasites as immunomodula-
tory factors, which are responsible for modu-
lation or blockage of the effective immune 
response of the host (Allen and Macdonald 
1998; Holland et al., 2000; Maizels and 
Yazdanbakhsh, 2003; Nisbet et al., 2010). 
Previously we have reported that calreticulin 
of filarial parasite differs from host and helps 
in establishment of infection by modulating 
the complement system of host (Yadav et al., 
2014). Diethylcarbamazine (DEC), ivermec-
tin alone and in combination with albend-
azole are mainly microfilaricidal in nature 
and exert few effects on adult worms. Symp-
toms of resistance have been reported for al-
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bendazole and ivermectin (Osei-
Atweneboana et al., 2007; Schwab et al., 
2007), therefore attempts are now being con-
tinued to identify new macrofilari-
cides/embryostatic agents with microfilari-
cidal activity to reduce or eradicate the prob-
lem of emerging drug resistance. The availa-
bility of the complete genome information 
for B. malayi will help to identify of the key 
enzyme that can be utilized as a drug target.  
Protein disulfide isomerases (PDIs) are 
emerging as essential factors in health and 
disease in modern era (Grek and Townsend, 
2014). The cell surface or secretory proteins 
are frequently synthesized in the endoplas-
mic reticulum (ER) where they slip into the 
secretory pathway to the cell surface. Disul-
fide bond formation is one of the crucial 
steps in protein folding. PDI also facilitates 
proteins to acquire their correct three dimen-
sional structure (Appenzeller-Herzog and 
Ellgaard, 2008; Hatahet and Ruddock, 2009). 
Misfolded proteins accumulating as large, 
insoluble aggregates hinder the cell function 
(Stefani, 2004). Rapid and effective protein 
folding is a fundamental requirement for cell 
viability, and disulfide bonds maintain added 
stability to proteins by covalently cross-
linking two cysteines that provide the appro-
priate protein folding and conformation 
which act as co-receptors for cell reorganiza-
tion, and avoid cellular toxicity associated 
with ER stress and protein misfolding 
(Kimura et al., 2005; Tian et al., 2004). PDI 
has been shown to be involved in the produc-
tion of the cuticle in Caenorhabditis elegans 
(Eschenlauer and Page, 2003). PDI is a mul-
tifunctional protein and belongs to the thi-
oredoxin superfamily (Hong and Soong, 
2008). PDI is a most abundant and very im-
portant calalyst of ER depicted as an ER-
resident protein (Lambert and Freedman, 
1985). It is also reported that excreto-
ry/secretory (ES) proteins of schistosomes 
play important roles in modulating host im-
mune systems (Hewitson et al., 2009). PDI 
was also playing a role in Leishmania viru-
lence and survival (Achour et al., 2002). 
During cholera infection, it was reported that 
PDI played a role in discharge of cholera 
toxin (Tsai et al., 2001). In case of Human 
Immunodeficiency Virus, PDI licence the 
HIV to crawl into host cells (Gallina et al., 
2002). A recent study showed that PDI also 
played a crucial roles in antigen presentation 
by MHC I molecules (Raghavan et al., 
2008). All of the nematodes are sheathed in 
an exoskeleton (cuticle) and undergo four 
cuticle moults from the L1 hatchling to the 
mature adult. In nematodes, non-reducible 
cross-links are responsible for strength and 
integrity of the cuticle (Page, 2013; Myl-
lyharju and Kivirikko, 2004). The modifica-
tion that is required to stabilise the final as-
sembled collagen triple helix, is formed by 
protein disulfide isomerase (Winter et al., 
2007). 
Ryser and co-workers were reported the 
potential role of PDI in the internalization of 
pathogens (Ryser et al., 1994). Santos and 
co-workers hypothesized that PDI involved 
in the reduction of the disulfide bonds pre-
sent on the parasite surface, that help in the 
internalization of the parasite (Santos et al., 
2009). Therefore, all the information re-
ceived marks towards the significance of 
PDI in the host immune response and cell 
invasion process in many stages of cell func-
tion and development. In spite of this a lot 
has been studied about PDIs in higher eukar-
yotes. Limited information is available re-
specting PDIs in filarial worms that are im-
portant for human infections, so the present 
study aims to characterize this protein in B. 
malayi. Previously in our lab we have 
cloned, expressed and purified many im-
portant drug target proteins like Brugia 
malayi Thymidylate kinase, Brugia malayi 
Calreticulin, Brugia malayi Glucose 6-
phosphate dehydrogenase, Plasmodium fal-
ciparum Purine Nucleoside Phosphorylase 
etc. and performed their biochemical, bio-
physical and inhibition studies (in detail: 
Doharey et al., 2016; Yadav et al., 2014; 
Verma et al., 2013, 2016; Suthar et al., 
2013a, b; Balaramnavar et al., 2014; Singh et 
al., 2015). 
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The present communication reports the 
cloning, expression and characterization of 
the recombinant PDI of B. malayi (rBmPDI) 
with the aim of understanding the differences 
between the host and parasitic enzyme which 
can be fruitfully utilized for designing of se-
lective inhibitors with potential antifilarial 
activity. 
 
MATERIAL AND METHODS 
Materials 
All the reagents were procured from 
Sigma (St. Louis, MO, USA). Ni–NTA aga-
rose and gel elution kit were purchased from 
Qiagen (Germany). IPTG, pre-stained mark-
ers and restriction enzymes (NdeI and XhoI), 
cDNA synthesis kit and T4 ligase were pur-
chased from MBI Fermentas (Hanover, MD, 
USA). Sephadex 200HR gel filtration col-
umn was purchased from GE Health- care. 
pET28a (+) expression vector was purchased 
from Novagen (Madison, WI, USA). 
pGEMT cloning vector and Taq DNA poly-
merase were purchased from Promega (Mad-
ison, WI, USA). All the animal handling was 
done by taking the permission of Institution-
al Animal Ethics Committee (IAEC) of 
CSIR-CDRI, Government of India. 
 
Maintenance of B. malayi infection 
6–8 week old male mastomys were inoc-
ulated with 200 L3 of B. malayi. The infec-
tive larvae developed into adult parasites and 
microfilariae appeared in the blood of infect-
ed animals after 90 days. The adult parasites 
were collected from peritoneal cavity of in-
fected animals in phosphate-buffered saline 
(PBS) (Singh et al., 2008).  
 
3D structure generation, optimization and 
evaluation  
The 3 dimensional structure of BmPDI 
protein was generated through Swiss model-
ler based on the information gained from se-
quence alignment. Energy minimization of 
the predicted structure was done in two steps 
firstly, the hydrogen bonding network was 
optimized and then knowledge-based force 
fields were used to apply atomic-level ener-
gy minimization by 3Drefine 
(http://sysbio.rnet.missouri.edu/3Drefine). 
The residue profiles of the three-dimensional 
models were further checked using VERI-
FY3D (Eisenberg et al., 1997). In order to 
assess the overall stereo chemical quality of 
the modelled protein, Ramachandran plot 
analysis was performed using the program 
Rampage and PROCHECK. Quality of gen-
erated models was evaluated by PROSA 
analysis (Laskowski et al., 1996; Wieder-
stein and Sippl, 2007). The modelled struc-
ture was then superimposed on the crystal 
template without altering the coordinate sys-
tems of atomic position in the template to 
analyse the root mean square deviation 
(RMSD) of the backbone atoms. The 3D x-
ray structure of BmPDI has not been yet re-
ported; hence we hope that the prediction of 
these structures will provide an insight to not 
only their individual structures but also to 
the BmCRT-BmPDI complex. The second-
ary structure predictions have been carried 
out by the self-optimized prediction method 
(SOPM) server with output width 70, the se-
quence of Brugia malayi protein disulfide 
isomerase was submitted in the FASTA for-
mat and the results were analysed.  
 
cDNA synthesis and polymerase chain  
reaction (PCR) 
Total RNA of B. malayi was isolated us-
ing the TRIzol reagent (Invitrogen) and syn-
thesis of cDNA was carried out using cDNA 
synthesis kit (Invitrogen, USA). The quality 
of isolated RNA was checked on 1.0 % (w/v) 
agarose gel. About 20 ng RNA was subject-
ed to cDNA synthesis using cDNA Cycle Kit 
(Invitrogen, USA). The putative BmPDI 
gene was PCR amplified from the cDNA of 
the parasite using gene-specific forward pri-
mers 5′ CATATGGATGGCATGGCAGC-
TATGA TTAGG 3′ having the NdeI restrict-
ion site and the reverse primer 5′ CTCGAG-
TTCAGTATGCTGTGCTTCTTCATC 3′ 
having the XhoI restriction site designed on 
the basis of sequence information available 
at http://www.kegg.jp/. PCR amplification 
consisted of 30 cycles (30 s at 94 °C, 1 min 
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at 61.3 °C and 2 min at 72 °C), followed by 
extension cycle (10 min at 72 °C) on a PTC 
200 PCR system (MJ Research, USA). The 
amplified BmPDI PCR product was eluted 
and ligated into pGEMT-easy cloning vector. 
E. coli DH5α cells were transformed with the 
ligated product and grown overnight on agar 
plates supplemented with 100 µg/ml ampicil-
lin. Correct recombinants were identified by 
restriction digestion and sequencing. This re-
combinant plasmid (pGEMT-BmPDI) was 
further sub cloned in pET-28a+ expression 
vector system using NdeI and XhoI re-
striction enzymes. Positive clones were fur-
ther confirmed by restriction digestion anal-
ysis.  
 
Overexpression and purification of BmPDI 
The E. coli BL-21 strain harbouring pET-
BmPDI plasmid was grown overnight in Lu-
ria–Bertini (LB) medium at 37 °C, supple-
mented with 50 µg/ml kanamycin. Culture 
was induced by addition of 1 mM IPTG for 
overexpression of the gene of interest and 
grown for an additional 16–18 h at 20 °C 
with shaking and cells were harvested by 
centrifugation at 10,000 rpm for 3 min. The 
frozen cells were thawed in lysis buffer (50 
mM NaH2PO4, 300 mM NaCl, 5 mM imid-
azole, 0.1 % (v/v) Tween-20 and 10 mM β-
mercaptoethanol) containing protease inhibi-
tor cocktail (Sigma) and lysed by pulse soni-
cation (Ultrasonic processor, Model-XL-
2020, Germany). The supernatant obtained 
after centrifugation at 10,000 ×g for 45 min 
was loaded on Ni2+–NTA column pre-
equilibrated with lysis buffer. The contami-
nating proteins were removed by subsequent 
three washes with washing buffers contain-
ing (50 mM Na2HPO4, 200 mM NaCl, 30 
mM Imidazole), (50 mM Na2HPO4, 200 mM 
NaCl, 50 mM Imidazole) and (50 mM 
Na2HPO4, 200 mM NaCl, 100 mM Imidaz-
ole). Recombinant protein was finally eluted 
by elution buffer (50 mM Na2HPO4, 200 
mM NaCl, 250 mM Imidazole). For all ex-
periments the purified BmPDI was dialyzed 
overnight against 50 mM Na2HPO4, 150 mM 
NaCl, pH 8 buffer.  
Size exclusion chromatography (SEC) and 
cross-linking analysis 
The native molecular mass of BmPDI 
was determined with the help of a calibration 
curve between elution volume and log mo-
lecular mass (kDa) of standard marker pro-
teins by the Superdex 200 HR 10/300 col-
umn (manufacturer’s exclusion limit 600 
kDa for proteins) on AKTA FPLC (Amer-
sham Pharmacia Biotech, Sweden). The gel 
filtration column was run in 50 mM sodium 
phosphate buffer (pH 8) containing 200 mM 
NaCl at a flow rate of 0.3 ml/min, with de-
tection at 280 nm. The native molecular 
weight of rBmPDI was further confirmed by 
glutaraldehyde cross linking experiment 
(Bhatt et al., 2002). 
 
Protein disulfide isomerase assay  
The BmPDI activity was measured by re-
folding of reduced denatured RNase A. The 
increase in absorbance at 260 nm, is moni-
tored the hydrolysis of RNA catalyzed by the 
refolded RNase A (Lyles and Gilbert, 1991). 
Denatured RNase A was first incubated with 
BmPDI (2.5 µg/mL) and sampled for 2, 5, 
and 7 min. into the refolding reaction. The 
refolded RNase A was then allowed to react 
with ribonucleic acid. This final reaction 
mixture contained 47 mM sodium phosphate, 
4.7 mM EDTA, 1 mM DTT, 0.0025 % (w/v) 
denatured RNase A, 0.5 mM acetic acid, and 
2.5 μg BmPDI in 1 mL reaction mix. 
 
Generation of polyclonal antibodies and 
Western immunoblotting 
Polyclonal antibodies against rBmPDI 
were raised in 6 months old rabbits. 250 μg 
purified rBmPDI protein was emulsified 
with an equal volume of Freund’s complete 
adjuvant (Sigma, USA) and injected subcu-
taneously in a 6-month old rabbit. Two 
booster doses of 150 μg rBmPDI, in 
Freund’s incomplete adjuvant (Sigma, USA), 
were given after the 3rd and 5th week. The 
rabbit serum was collected after 7 days of the 
second booster dose and the antibody titre 
was measured by ELISA. Samples of 50 μg 
of recombinant protein were resolved on 
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10 % (w/v) SDS–PAGE gel and electro-
blotted onto the nitrocellulose membrane 
(Sambrook et al., 1989). The membrane was 
probed with anti-BmPDI serum (1:10 000 di-
lution) as the primary antibody, followed by 
HRP-conjugated antirabbit IgG as the sec-
ondary antibody. The blot was developed by 
chromogenic peroxidase reaction with 3,3′-
diaminobenzidine (Singh et al., 2008). 
 
Effect of pH and temperature  
To determine optimal pH, the activity 
was measured at different pH and effect of 
temperature on enzyme was measured by in-
cubation for 10 min at different temperatures 
and determined the residual activity.  
 
Effect of antifilarials and specific  
inhibitors 
The effect of antifilarials viz., DEC, 
ivermectin, suramin, levamisole, and syn-
thetic compounds viz., aurin and specific in-
hibitors of PDI bacitracin and ribostamycin 
on BmPDI activity were studied by incubat-
ing the enzyme with these compounds for 10 
min at 25 °C and measuring the activity. 
 
Interaction of BmPDI with BmCRT  
i. Solid phase binding assay  
Microtiter plate was coated with 
100 µl/well of purified recombinant BmCRT 
(0 to1.5µg) diluted in carbonate buffer 
(15 mM of Na2CO3, 35mM of NaHCO3, pH 
9.6) for 6 h at room temperature. Control 
wells contained buffer and BSA. Following 
three washes with 0.05 % Tween 20 in PBS 
(PBST), the wells were blocked with 150 µl 
of 5 % skimmed milk in PBS for 2 h at 
37 °C. 0 to 5 µg of BmPDI in 100 µl of 20 
mM Tris-HCl (pH 7.4) containing 50 mM 
NaCl and 1 mM CaCl2 was added to each 
well and the plate was incubated at 4 oC 
overnight. The plate was washed three times 
with PBST and 100 µl of rabbit anti-BmPDI 
(at 1:1500 dilution) was added to each well. 
After 2 h, wells were washed once again 
three times as described earlier and binding 
was detected by probing with HRP-
conjugated goat anti-rabbit IgG (at 1:3000 
dilutions). The plate was kept at room tem-
perature for 2 h followed by washing with 
PBST. Bound peroxides activity was meas-
ured by adding OPD (Orthophenyl diamine 
dihydrochloride, SIGMA) as substrate. The 
developed color was read at 490 nm in a mi-
croplate reader. The data are given as an av-
erage experiment ± standard deviation (SD).  
ii. Protein-Protein Docking 
Information driven flexible docking algo-
rithm called High Ambiguity Driven protein-
protein DOCKing (HADDOCK) was used 
for docking the predicted three dimensional 
structures of CRT and PDI proteins of B. 
malayi (Dominguez et al., 2003). The ab-
initio based docking systems do not take ex-
perimental information into account, as most 
of the computational search and screen use 
experimental knowledge hence we opted the 
knowledge-based approach to analyse the in-
teractions between two proteins. First of all 
the topology of the molecule is generated, 
then a rigid-body energy minimization ap-
proach is followed. Semi-flexible and flexi-
ble refinement in torsion angle space and in 
explicit solvent respectively is done. In each 
stage the structures are scored and ranked, 
the best structures are then carried forward to 
the next stage. HADDOCK uses Crystallo-
graphic and NMR system as structure calcu-
lation engine. HADDOCK performs cluster-
ing on maximum of 200 models. HAD-
DOCK score is the weighted sum of Electro-
static energy, Van der Waals energy, 
Desolvation energy and Restraints violation 
energies. It also performs comparison to the 
reference structure. 
 
Analysing protein-protein interactions 
The interactions between the predicted 
BmPDI and BmCRT protein model of B. 
malayi were visualised through academic 
version of Pymol. A separate python script 
“InterfaceResidues.py” was used to analyse 
the interacting interface residues of both the 
proteins. The specific protein-protein inter-
acting residues were examined through 
PDBSUM (Laskowski, 2001). 
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RESULTS 
Sequence analysis and 3D structure  
generation 
The amino acid sequence alignment of B. 
malayi Protein disulfide isomerase with C. 
elegans, human, mouse, Leishmania major, 
Leishmania Donovani, trypanosome, yeast, 
and E. coli Protein disulfide Isomerases was 
carried out by Clustal W to determine the ex-
tent of their homology. Phylogenetic rela-
tionship of BmPDI with PDIs of other organ-
isms showed that BmPDI is conserved in 
prokaryotes as well as in eukaryotes throug-
hout the path of evolution. Among eukaryot-
ic PDIs, BmPDI is closer to the C. elegans 
than human and mouse respectively and far 
from leishmania, trypanosome and yeast. 
BmPDI showed distant relationship with 
prokaryotic PDIs (Supplementary Figure 1). 
Protein disulfide isomerase of Brugia malayi 
and C. elegans exists as the sister node, same 
could be followed with Schizosaccharomy-
ces pombe and E. Coli, Mus musculus and 
Homo sapiens, Leishmania donoveni and 
Leishmania major, whereas Plasmodium fal-
ciparum exists as an outgroup node (Sup-
plementary Figure 2). 
Recently a new method called the self-
optimized prediction method (SOPM) has 
been described to improve the success rate in 
the prediction of the secondary structure of 
proteins. The sequence length was 487 ami-
no acids whose Alpha helix (Hh) accounts 
231 amino acids of about 47.43 %. The ex-
tended strand (Ee) had 82 amino acids ac-
counting 16.84 %, Beta turn (Tt) made up of 
37 amino acids making up 7.60 % and ran-
dom coil (Cc) made up of 137 amino acids 
accounting 28.13 %. There was no 310 helix 
(Gg), Pi helix (Ii), Beta bridge (Bb), Bend 
region (Ss), ambigous states and other states. 
The parameters were window width of 17 
with a similarity threshold 8 and the number 
of states is 4 (Geourjon and Deleage, 1995) 
(Supplementary Figure 3A, B, Supplemen-
tary Table 1). 
Based on the information obtained from 
BLAST, template model was selected PDB 
ID: 4EKZ, the three dimensional model of 
BmPDI was generated. The template strand 
was selected based on the maximum identity 
score and Coverage score, and E value score; 
also 4EKZ is the structure of Human protein 
disulfide isomerase and most of the regions 
are conserved in both the sequences, so we 
opted the same as template sequence. Bm-
CRT protein was modelled by taking 3RGO 
as the template sequence which showed 
maximum Identity score of Coverage score 
(Yadav et al., 2014).  
A three-dimensional model for BmPDI 
was produced by homology modelling (Fig-
ure 1). The refined model was subjected to a 
series of tests for its internal consistency and 
reliability. Comparing this result with that 
obtained for the human PDI, we found that 
the backbone conformations of our BmPDI 
model to be nearly as good as those of tem-
plate. 
 
Figure 1: (A) 3D structure 
of Brugia malayi protein 
disulfide isomerase gener-
ated with the help of Swiss 
Modeller; (B) 3D structure 
of Brugia malayi Calreticu-
lin generated with the help 
of Swiss Modeller 
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The Ramachandran plot showed normal 
distribution of points with phi (φ) values and 
psi (ψ) values clustered in a few distinct re-
gions with expected 98 % residues are in fa-
voured region (Supplementary Figure 4). 
The quality of BmPDI model checked by 
different criteria showed that the backbone 
conformation (PROCHECK) and the residue 
interaction (PROSA II) are well within the 
limits established for the reliable structures 
and these tests suggest that a good model for 
BmPDI is obtained which can be further 
used to explore its interactions with the sub-
strate, and inhibitors or protein-protein inter-
action (Supplementary Figure 5). 
 
Cloning, expression and purification of 
BmPDI 
Brugia malayi BmPDI was successfully 
cloned, expressed and purified by Ni2+-NTA 
affinity chromatography. The PCR product 
obtained by amplification of filarial cDNA 
was cloned into expression vector pET-28a+ 
and subsequent transformation of this con-
struct into E. coli strain Rosetta (DE3) ex-
pressed a soluble protein of expected size. 
The E. coli BL-21 strain harbouring pET-28a-
BmPDI plasmid was grown overnight in Lu-
ria–Bertini (LB) medium at 37 °C, supple-
mented with 50 µg/ml kanamycin. Induction 
of expression was carried out by the addition 
of isopropyl d-1-thiogalactopyranoside 
(IPTG) to a final concentration of 1 mM and 
cell growth was continued at 20 °C for 16 h. 
Cells were harvested by centrifugation at 
8000 × g for 5 min and pellet was resuspend-
ed in lysis buffer (50 mM NaH2PO4, 300 mM 
NaCl, 10 mM imidazole) pH 8.0 containing 
protease inhibitor cocktail (Sigma) and lysed 
by pulse sonication. Nickel affinity column 
(Ni2+–NTA) was used for single step purifica-
tion of 6XHis-tagged BmPDI protein. The 
protein was eluted from the affinity column 
with 250 mM imidazole. The sub-unit molec-
ular mass of rBmPDI was determined by 
10 % SDS-PAGE according to the method of 
Laemmli (1970). A subunit molecular mass of 
54 kDa was obtained for expressed and puri-
fied BmPDI by SDS-PAGE (Figure 2A). 
Specificity of anti-BmPDI antibodies and 
Western immunoblotting 
The titre of anti-BmPDI antibody raised 
against recombinant protein was found to be 
1:64,000. Western immunoblotting illus-
trates the specificity of the antibody for the 
purified recombinant BmPDI (Figure 2B). 
 
A 
 
B 
 
Figure 2: Purification of rBmPDI expressed in E. 
coli. (A) 10 % SDS-PAGE analysis of purified re-
combinant BmPDI. Lane 1: Flow through from 
Ni-NTA Column; Lane 2: Washing of the column 
with 50 mM imidazole; Lane 3 & 4: Elution with 
200 mM imidazole; Lane 5: Elution with 250 mM 
imidazole. Pre-stained protein markers (Page 
Ruler TM, MBI, fermentas). (B) Western blot 
analysis using anti-BmPDI antibody as probe. 
Lane 1: Prestained protein marker. Lane 2: Puri-
fied protein. 
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Size exclusion chromatography and  
cross-linking analysis 
The Sephadex-200 column was calibrat-
ed with standard molecular markers. The na-
tive molecular weight of rBmPDI was found 
to be 54 kDa as obtained by size-exclusion 
chromatography, indicating that rBmPDI is a 
monomer. Monomeric nature of BmPDI was 
further confirmed by interchain cross-linking 
of BmPDI using glutaraldehyde as cross-
linker. The cross-linked product when ana-
lyzed by 10 % SDS-PAGE showed a band at 
54 kDa (Figure 3A-C). 
 
Spectrophotometric assay of recombinant 
BmPDI 
As an approach to characterize the bio-
logical activity of the recombinant protein 
we used a spectrophotometric assay to inves-
tigate the catalyzed refolding of reduced and 
denatured RNase in the presence of various 
amounts of purified recombinant BmPDI. 
The results indicated that BmPDI was able to 
readily refold scrambled RNase, confirming 
its ability to catalytically rearrange the incor-
rect substrate disulfide bonding (Figure 4A, 
B). 
 
Optimum pH and temperature for BmPDI 
Activity 
The effect of pH on enzyme activity was 
determined by using buffers of different pH 
(6-10.5). The recombinant enzyme exhibited 
activity at broad range of pH but maximum 
activity was observed at pH 8 (Figure 5A). 
The optimum temperature for enzyme activi-
ty was found to be 40 °C (Figure 5B). 
 
 
(C) 
 
 
 
 
 
 
 
Figure 3: Determination of molecular mass of 
recombinant BmPDI. (A) Size exclusion chromatography profile of native BmPDI with absorbance 
at 280 nm. (B) The native molecular mass of the protein was determined by FPLC using Sephadex 
200HR 10/300 gel filtration column. The column was calibrated with molecular weight standard 
markers: a – Ova-albumin (42.7 kDa), b - albumin (67 kDa), c - aldolase (158 kDa), and d - apofer-
ritin (443 kDa), Arrow indicates the native molecular mass of BmPDI. (C) 10 % SDS–PAGE profile 
of glutaraldehyde cross-linked samples, Lane 1: Molecular weight standard markers, Lane 2: Native 
rBmPDI, Lane 3: Cross-linked rBmPDI with 0.1 % glutaraldehyde. 
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Figure 4: Recovery of RNase activity in the presence of rBmPDI. (A) Catalysis of folding of 
scrambled RNase as a measure of disulfide isomerization by rBmPDI. (B) Showing the activity of 
BmPDI in the presence of various concentrations of substrate. The values are the mean of three sepa-
rate experiments. 
Figure 5: Effect of pH and temperature on the activity of BmPDI. (A) Effect of PH: the optimum ac-
tivity was observed to be at PH 8. (B) Effect of temperature: the optimum temperature was found to be 
at 40 °C. 
 
 
Interaction of BmPDI with BmCRT  
The BmPDI interacts with the BmCRT in 
dose dependent and saturable manner. Strong 
binding was observed at concentration 
5 µg/ml of BmPDI and 8 µg/ml of BmCRT 
as shown in Figure 6.  
 
Effect of antifilarials and specific inhibitor  
The antiparasitic compound aurin and su-
ramin inhibited recombinant BmPDI by 
80 % and 38 % at 50 µM concentration re-
spectively, while the ivermectin, DEC, and 
levamisole exhibited no significant effect. 
The IC50 value for levamisole, suramin and 
aurin was found to be 116.29, 74.21, 17.61 
µM respectively. Percentage inhibition was 
determined at different concentrations of in-
hibitors against BmPDI and IC50 was deter-
mined by Excel based line graphic template 
after plotting conc. values of each sample 
vs.  % inhibition on x and y axis.  
The effect of specific inhibitor bacitracin 
and ribostamycin were tested on the enzy-
matic activity of rBmPDI. The results show 
that ribostamycin is more potent than baci-
tracin, as it inhibited the enzyme activity by 
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Figure 6: Dose dependent interaction between BmPDI and BmCRT by solide-phase binding assay. 
Microtiter plate was coated with 0 to 1.5 µg purified recombinant BmCRT in carbonate buffer. Control 
wells contained buffer and BSA. The wells were blocked with 5 % skimmed milk in PBS for 2 h at 
37 °C. 0 to 5 µg of BmPDI in Tris-HCl buffer solution mentioned in method section was incubated at 
4 °C overnight. The plate was washed three times and binding was detected by probing with HRP-
conjugated goat anti-rabbit IgG.  
 
 
 
63 % and 78 % at 50 and 100 µM respective-
ly. The bacitracin inhibited 14 and 32 % ac-
tivity of rBmPDI at the same concentrations. 
The IC50 value for ribostamycin was found 
to be 35.64 µM (Table 1). 
 
 
Table 1: IC50 values of some antifilarials and 
specific compounds against BmPDI 
Compound Name         IC50 µM 
DEC 
Ivermectin 
Levamisole  
Suramin 
Aurin 
Bacitracin 
Ribostamycin 
78.34 
167.87 
116.29 
74.21 
17.61 
141.12 
35.64 
 
 
 
Protein-protein interactions 
Protein-Protein interactions are the most 
important part of the biological pathways 
network and important target for drug de-
sign. The binding site was obtained through 
literature search, where the amino acid resi-
dues 26-83 of the N-domain of PDI was 
found to interact with 150-240 amino acid 
residues P-domain of CRT protein (Yadav et 
al., 2014) (Figure 7). 
While viewing the interactions between 
the BmPDI and BmCRT proteins it was 
found that a total of 42 and 28 residues were 
found to be involved in interactions from 
BmCRT and BmPDI proteins respectively. 
Interface surface area of protein-protein 
complex was 1443 Å2 for BmCRT protein 
and 1642 Å2 for BmPDI protein. A total of 
25 hydrogen bonds were found to be formed 
between two interfaces. There are 259 non-
bonded contacts present in the BmPDI-
BmCRT complex and 12 salt bridges were 
formed in the interaction (Figure 8). 
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Figure 7: Protein-Protein Interaction. The table in the figure shows the statistics of the residues in-
volved; the upside arrow points towards the figure pertaining gross number of residues taking part in 
interaction; while the arrow pointing sideways emulates the specific residues taking part in protein-
protein complex formation. 
Figure 8: Protein-Protein interaction between modelled BmCRT (Blue) and BmPDI (Red): (A) Inset 
shows the associated complex with hydrophobic surface view; (B) The interacting residues represent-
ed in sticks while non-interacting part depicted in cartoon form; (C) Showing surface interactions be-
tween two proteins. 
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The amino acid residues mainly contrib-
uting in the interaction are shown in Figure 
7. In general Lys36 , Asp37, val91, Lys62, 
Glu26, glu27, Cys87, Gln73, lys70, Lys76 and 
Lys77 of BmPDI were involved in hydrogen 
bond formation with Glu215, Glu219, Trp217, 
Pro214, Lys213, Lys 286, His289, Ala211, Glu291, 
Phe200, Lys156, and Lys157 of BmCRT.  
 
DISCUSSION 
Protein folding is a complicated process 
which is essential to acquire biological func-
tion. Parasites have developed antioxidant 
defences and redox balance mechanisms for 
their protection from the Reactive Oxygen 
Species produced by host immune responses 
and also protect themselves against oxidative 
stress due to their own oxygen metabolism 
(Suttiprapa et al., 2008; Wang et al., 2013). 
Protein disulfide isomerases are regarded as 
an essential member of the extracellular anti-
oxidant sword of this parasite with a crucial 
role in parasite–host cell interaction. A re-
cent study reported that PDIs may also be 
secreted to the cell surface in some cells 
(Naguleswaran et al., 2005). Proper folding 
of proteins is necessary for parasite repro-
duction, development and play a pivotal role 
in host parasite interactions. Recently it was 
shown that PDI is vigorously expressed in 
the uterus wall and oocyte of female adult A. 
cantonensis worms (Liu et al., 2012). The 
formation and maturation of proteins occur 
throughout the whole life and vitellogenins 
are prevalent proteins in adult female  nema-
todes that are  synthesized in a large amount 
to support developing oocytes (Nisbet et al., 
2010). In nematodes, the cuticle, synthesized 
by the hypodermis is a necessary collagen-
ous extracellular matrix (ECM) has funda-
mental role for survival of nematodes and 
can insulate them against adverse environ-
mental conditions. Protein disulfide isomer-
ase of Brugia malayi and C. elegans exists as 
the sister node, similar to Schizosaccharo-
myces pombe, Escherichia Coli, Mus muscu-
lus, Homo sapiens, Leishmania donoveni and 
Leishmania major. Where as in Plasmodium 
falciparum it exists as an out-group node. 
PDI is one of the richest proteins in the ER 
(Lyles and Gilbert, 1991). BmPDI was ex-
pressed as a soluble protein of expected size 
of 54 kDa. On the other hand Clonorchis 
sinensis PDI is reported to be a monomer of 
52 kDa (Hu et al., 2012). Analysis of Leish-
mania genomes showed the presence of four 
distinct genes encoding for potential PDI 
proteins of 15, 40, 47 and 52 kDa that are 
highly conserved (Hong and Soong, 2008). 
A 52-kDa PDI of N. caninum techyzoites is 
involved in the adhesion of parasites to host 
cells (Naguleswaran et al., 2005). Mammali-
an PDI is a 57 kDa ER protein and exists as 
homodimer (Edman et al., 1985). BmPDI 
purified by Ni-NTA affinity chromatography 
was found to be of 54 kDa. Gel filteration 
chromatography and glutaraldehyde cross-
linking studies indicated the monomeric na-
ture of protein. In addition to the role of PDI 
in proline hydroxylation, it has been also 
shown that PDI 2 is involved in the oxidative 
registration step in C. elegans while muta-
tions in pdi-2 cause severe cuticle disruption 
and adult fecundity, whereas the mixed mu-
tations of pdi-1, pdi-2 and pdi-3 cause em-
bryonic lethality which clearly shows the 
importance of PDI in nematodes (Winter et 
al., 2007). The results of the kinetic proper-
ties of BmPDI indicated that the enzyme is 
able to readily refold scrambled RNase, con-
firming its ability to catalytically rearrange 
the incorrect substrate disulfide bonding. The 
maximum activity was observed at pH 8 and 
the optimum temperature for enzyme activity 
was found to be 40 °C. In Leishmania ama-
zonensis PDI, the optimum pH was found to 
be 8, while in Entamoeba histolytica and 
Fasciola hepatica PDI, the optimum pH was 
7 and pH 8 respectively (Hong and Soong 
2008; Salazar-Calderon et al., 2003; Ramos 
et al., 2011). The titer of anti-BmPDI anti-
bodies was estimated by ELISA which was 
found to be 1:64,000. The calreticulin inter-
acts with protein disulfide isomerase (Baksh 
et al., 1995). We also showed the interaction 
of BmPDI and BmCRT in a concentration 
dependent manner. The C-domain of calre-
ticulin is acidic and binds Ca+2 with high ca-
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pacity and low affinity, whereas the P-
domain binds 1 mol of Ca+2 with high affini-
ty (Baksh and Michalak, 1991). While view-
ing the interactions between the BmPDI and 
BmCRT proteins it was found 42 and 28 res-
idues were involved in interaction of 
BmCRT and BmPDI proteins respectively. 
Interface surface area of protein-protein 
complex was 1443 Å2 for BmCRT protein 
and 1642 Å2 for BmPDI protein. A total of 
25 hydrogen bonds were found to be formed 
between two interfaces. PDI and calreticulin 
belong to a family of the resident ER pro-
teins (Edman et al., 1985). PDI and calreticu-
lin have been proposed to be multifunctional 
proteins capable of interaction with a variety 
of proteins (Noiva and Lennarz, 1992; 
Freedman et al., 1994). Importantly, interac-
tion between PDI and calreticulin leads to 
modulation of their functions (Baksh et al., 
1995). Furthermore, expression of calreticu-
lin domains and PDI as fusion proteins with 
GAL4 in the yeast two-hybrid system re-
vealed that the N and P-domain of calreticu-
lin interact with PDI under normal cellular 
conditions. The interaction with PDI requires 
only the amino-terminal region of the N do-
main (amino acid residues 1– 83) of calretic-
ulin. This is one of the most conserved re-
gions of the amino acid sequence of calretic-
ulins (Baksh et al., 1995). As peptides and 
protein are two different entities and binding 
study with whole protein may show whole 
range of interactions. In full length protein 
only some of these sites should be surface-
oriented (Naresha et al., 2009). A total of 25 
hydrogen bonds, 12 salt bridges and 259 
non-bonded contacts were observed in the 
BmPDI-BmCRT complex. The effect of spe-
cific inhibitor on BmPDI showed that ri-
bostamycin inhibited the enzyme activity by 
78 % at 100 µM concentration while bacitra-
cin did not show significant effect. Bacitra-
cin has been shown to inhibit Leishmania 
major PDI activity, on the other hand, Ri-
bostamycin, a bovine PDI chaperone inhibi-
tor, did not show any inhibitory effect on 
Leishmania major PDI activity (Achour et 
al., 2002). It was shown that bacitracin de-
creased L. amazonensis promastigote PDI 
activity by 50 % which further supported the 
view that PDIs play an important role in 
Leishmania natural pathogenicity and may 
serve as new target for chemotherapy 
(Achour et al., 2002). Ramos et al. (2011) 
reported that bacitracin can be a good inhibi-
tor for Entamoeba histolytica PDI. In case of 
Besnoitia besnoiti protein disulfide isomer-
ase (BbPDI) also showed sensitivity to baci-
tracin in a dose-dependent manner (Mar-
celino et al., 2011). The antifilarials did not 
show significant effect on BmPDI, however 
suramin and levamisole inhibited the enzyme 
activity 38 and 30 % at 50 µM concentration 
respectively. The synthetic compound aurin 
inhibited recombinant BmPDI by 80 % at 
50 µM concentration, while the ivermectin 
and DEC, exhibited no significant effect. 
BmPDI might plays a major role in correct 
folding of immunomodulatory and secretory 
proteins and isomerisation of the proteins 
having disulfide bonds. Disulfide bond syn-
thesis has a crucial role in cross-linking dur-
ing chitin synthesis in filarial parsites.  
 
CONCLUSION 
In the present study B. malayi gene en-
coding Protein disulfide isomerase was suc-
cessfully cloned, expressed and character-
ized. Results of the above study indicate that 
it can be utilized further for study and to ex-
plore the properties of BmPDI. Aurin and 
PDI inhibitors showed inhibition of the 
rBmPDI. rBmPDI interacts with rBmCRT in 
dose-dependent manner, furthermore these 
results were also supported by docking stud-
ies. The information obtained in the present 
study may be exploited in the design of para-
site specific protein disulfide isomerase in-
hibitors. 
 
REFERENCES 
Achour YB, Chenik M, Louzir H, Dellagi K. Identifi-
cation of a disulfide isomerase protein of Leishmania 
major as a putative virulence factor. Infect Immun. 
2002;70:3576-85. 
EXCLI Journal 2017;16:824-839 – ISSN 1611-2156 
Received: February 13, 2017, accepted: April 11, 2017, published: June 01, 2017 
 
 
837 
Allen JE, Macdonald AS. Profound suppression of 
cellular proliferation mediated by the secretions of 
nematodes. Parasite Immunol. 1998;20:241-7. 
Appenzeller-Herzog C, Ellgaard L. The human PDI 
family: versatility packed into a single fold. Biochim 
Biophys Acta. 2008;1783:535-48. 
Baksh S, Michalak M. Expression of calreticulin in 
Escherichia coli and identification of its Ca2+ binding 
domains. J Biol Chem. 1991;266:21458-65. 
Baksh S, Burns K, Andrin C, Michalak M. Interaction 
of calreticulin with protein disulfide isomerase. J Biol 
Chem. 1995;270:31338-44. 
Bhatt AN, Prakash K, Subramanya HS, Bhakuni V. 
Different unfolding pathways for mesophilic and 
thermophilic homologues of serine hydroxymethyl-
transferase. Biochemistry. 2002;41:12115-23. 
Balaramnavar VM, Srivastava R, Rahuja N, Gupta S, 
Rawat AK, Varshney S, et al. Identification of novel 
PTP1B inhibitors by pharmacophore based virtual 
screening, scaffold hopping and docking. Eur J Med 
Chem. 2014;87:578-94.  
Doharey PK, Suthar MK, Verma A, Kumar V, Yadav 
S, Balaramnavar VM, et al. Molecular cloning and 
characterization of Brugia malayi thymidylate kinase. 
Acta Trop. 2014;133:83-92.  
Doharey PK, Singh SK, Verma P, Verma A, Rathaur 
S, Saxena JK. Insights into the structure-function rela-
tionship of Brugia malayi thymidylate kinase 
(BmTMK). Int J Biol Macromol. 2016;88:565-71.  
Dominguez C, Boelens R, Bonvin AM. HADDOCK: 
a protein-protein docking approach based on bio-
chemical or biophysical information. J Am Chem Soc. 
2003;125:1731-7. 
Edman JC, Ellis L, Blacher RW, Roth RA, Rutter WJ. 
Sequence of protein disulphide isomerase and impli-
cations of its relationship to thioredoxin. Nature. 
1985; 317(6034):267-70.  
Eisenberg D, Lüthy R, Bowie JU. VERIFY3D: As-
sessment of protein models with three-dimensional 
profiles. Meth Enzymol 1997;277:396-404. 
Eschenlauer SC, Page AP. The Caenorhabditis ele-
gans ERp60 homolog protein disulfide isomerase-3 
has disulfide isomerase and transglutaminase-like 
cross-linking activity and is involved in the mainte-
nance of body morphology. J Biol Chem. 
2003;278:4227-37. 
Freedman RB, Hirst TR, Tuite MF. Protein disulphide 
isomerase: building bridges in protein folding. Trends 
Biochem Sci. 1994;19:331-6. 
Gallina A, Hanley TM, Mandel R, Trahey M, Broder 
CC, Viglianti GA, et al. Inhibitors of protein-disulfide 
isomerase prevent cleavage of disulfide bonds in re-
ceptor-bound glycoprotein 120 and prevent HIV-1 en-
try. J Biol Chem. 2002;277:50579-88. 
Geourjon C, Deleage G. SOPMA: significant im-
provements in protein secondary structure prediction 
by consensus prediction from multiple alignments. 
Computer Applicat Biosci: CABIOS. 1995;11: 681-4.  
Grek C, Townsend DM. Protein disulfide isomerase 
superfamily in disease and the regulation of apoptosis. 
Endoplasmic Reticulum Stress Dis. 2014;1(1):4-17. 
Hatahet F, Ruddock LW. Protein disulfide isomerase: 
a critical evaluation of its function in disulfide bond 
formation. Antioxid Redox Signal. 2009;11:2807-50. 
Hewitson JP, Grainger JR, Maizels RM. Helminth 
immunoregulation: the role of parasite secreted pro-
teins in modulating host immunity. Mol Biochem 
Parasitol. 2009;167:1-11. 
Holland MJ, Harcus YM, Riches PL, Maizels RM. 
Proteins secreted by the parasitic nematode Nip-
postrongylus brasiliensis act as adjuvants for Th2 re-
sponses. Eur J Immunol. 2000;30:1977-87. 
Hong BX, Soong L. Identification and enzymatic ac-
tivities of four protein disulfide isomerase (PDI) 
isoforms of Leishmania amazonensis. Parasitol Res. 
2008;102:437-46. 
Hu Y, Huang L, Huang Y, He L, Zhang, F, Li W, et 
al. Molecular cloning, expression, and immunolocali-
zation of protein disulfide isomerase in excretory–
secretory products from Clonorchis sinensis. Parasitol 
Res. 2012;111:983-9. 
Kimura T, Hosoda Y, Sato Y, Kitamura Y, Ikeda T, 
Horibe T, et al. Interactions among yeast protein-
disulfide isomerase proteins and endoplasmic reticu-
lum chaperone proteins influence their activities. J 
Biol Chem. 2005;280:31438-41. 
Laemmli UK. Cleavage of structural proteins during 
the assembly of the head of bacteriophage T4. Nature. 
1970;227:680–5.  
Lambert N, Freedman RB. The latency of rat liver 
microsomal protein disulphide-isomerase. Biochem J. 
1985;228:635-45. 
Laskowski RA. PDBsum: summaries and analyses of 
PDB structures. Nucleic Acids Res. 2001;29:221-2. 
EXCLI Journal 2017;16:824-839 – ISSN 1611-2156 
Received: February 13, 2017, accepted: April 11, 2017, published: June 01, 2017 
 
 
838 
Laskowski RA, Rullmann JAC, MacArthur MW, 
Kaptein R, Thornton JM. AQUA and PROCHECK-
NMR: programs for checking the quality of protein 
structures solved by NMR. J Biomol NMR. 1996;8: 
477-86. 
Lyles MM, Gilbert HF. Catalysis of the oxidative 
folding of ribonuclease A by protein disulfide isomer-
ase: dependence of the rate on the composition of the 
redox buffer. Biochemistry. 1991;30:613-9. 
Maizels RM, Yazdanbakhsh M. Immune regulation 
by helminth parasites: cellular and molecular mecha-
nisms. Nat Rev Immunol. 2003;3:733-44. 
Marcelino E, Martins TM, Morais JB, Nolasco S, 
Cortes H, Hemphill A, et al. Besnoitia besnoiti protein 
disulfide isomerase (BbPDI): molecular characteriza-
tion, expression and in silico modelling. Exp Parasi-
tol. 2011;129:164-74. 
Michael E, Bundy DAP, Grenfell BT. Re-assessing 
the global prevalence and distribution of lymphatic 
filariasis. Parasitology. 1996;112:409-28. 
Michalak M, Corbett EF, Mesaeli N, Nakamura K, 
Opas M. Calreticulin: one protein, one gene, many 
functions. Biochem J. 1999;344:281–92.  
Myllyharju J, Kivirikko KI. Collagens, modifying en-
zymes and their mutations in humans, flies and 
worms. Trends Genet. 2004;20:33-43. 
Naguleswaran A, Alaeddine F, Guionaud C, Vonlau-
fen N, Sonda S, Jenoe P, et al. Neospora caninum 
protein disulfide isomerase is involved in tachyzoite-
host cell interaction. Int J Parasitol. 2005;35:1459-72. 
Naresha S, Suryawanshi A, Agarwal M, Singh BP, 
Joshi P. Mapping the complement C1q binding site in 
Haemonchus contortus calreticulin. Mol Biochem 
Parasitol. 2009;166:42-6. 
Nisbet AJ, Bell NE, McNeilly TN, Knox DP, Maizels 
RM, Meikle LI, et al. A macrophage migration inhibi-
tory factor-like tautomerase from Teladorsagia cir-
cumcincta (Nematoda: Strongylida). Parasite Immu-
nol. 2010;32:503-511. 
Noiva R, Lennarz WJ. Protein disulfide isomerase. A 
multifunctional protein resident in the lumen of the 
endoplasmic reticulum. J Biol Chem. 
1992;267.6:3553-6. 
Osei-Atweneboana MY, Eng JK, Boakye DA, Gya-
pong JO, Prichard RK. Prevalence and intensity of 
Onchocerca volvulus infection and efficacy of iver-
mectin in endemic communities in Ghana: a two-
phase epidemiological study. Lancet. 
2007;369(9578):2021-9. 
Page AP. The Nematode cuticle: synthesis, modifica-
tion and turnover. In: Kennedy MW, Harnett W (eds): 
Parasitic nematodes. Molecular biology, biochemistry 
and immunology (pp 337-50). Wallingford, Oxford-
shire: CABI, 2013. 
Liu Q, Yang X, Zhang M, Wang L, Liu J, Chen J et 
al. Molecular characterization and immunolocaliza-
tion of a protein disulfide isomerase from Angiostron-
gylus cantonensis. Parasitol Res. 2012;110:2501-7.  
Raghavan M, Del Cid N, Rizvi SM, Peters LR. MHC 
class I assembly: out and about. Trends Immunol. 
2008;29:436-43. 
Ramos MA, Mares RE, Magana PD, Rivas ID, 
Melendez-Lopez SG. Entamoeba histolytica: bio-
chemical characterization of a protein disulfide iso-
merase. Exp Parasitol. 2011;128:76-81. 
Ryser HJ, Levy EM, Mandel R, DiSciullo GJ. Inhibi-
tion of human immunodeficiency virus infection by 
agents that interfere with thiol-disulfide interchange 
upon virus-receptor interaction. Proc Natl Acad Sci 
USA. 1994;91:4559-63. 
Salazar-Calderon M, Martin-Alonso JM, Castro AM, 
Parra F. Cloning, heterologous expression in Esche-
richia coli and characterization of a protein disulfide 
isomerase from Fasciola hepatica. Mol Biochem Para-
sitol. 2003;126:15-23. 
Sambrook J, Fritsch EF, Maniatis T. Molecular clon-
ing: A laboratory manual. Cold Spring Harbor, NY: 
old Spring Harbor Press, 1989. 
Santos CX, Stolf BS, Takemoto PV, Amanso AM, 
Lopes LR, Souza EB, et al. Protein disulfide isomer-
ase (PDI) associates with NADPH oxidase and is re-
quired for phagocytosis of Leishmania chagasi pro-
mastigotes by macrophages. J Leukocyte Biol. 
2009;86:989-98. 
Schwab AE, Churcher TS, Schwab AJ, Basanez MG, 
Prichard RK. An analysis of the population genetics 
of potential multi-drug resistance in Wuchereria ban-
crofti due to combination chemotherapy. Parasitology. 
2007; 134:1025-40. 
Singh AR, Joshi S, Arya R, Kayastha AM, Srivastava 
KK., Tripathi LM., et al. Molecular cloning and char-
acterization of Brugia malayi hexokinase. Parasitol 
Int. 2008;57:354-61. 
Singh VK, Doharey PK, Kumar V, Saxena JK, Siddi-
qi MI, Rathaur S, et al. Synthesis, molecular docking 
and Brugia malayi thymidylate kinase (BmTMK) en-
zyme inhibition study of novel derivatives of [6]-
shogaol. Eur J Med Chem. 2015;93:74-82.  
EXCLI Journal 2017;16:824-839 – ISSN 1611-2156 
Received: February 13, 2017, accepted: April 11, 2017, published: June 01, 2017 
 
 
839 
Stefani M. Protein misfolding and aggregation: new 
examples in medicine and biology of the dark side of 
the protein world. Biochim Biophys Acta. 2004;1739: 
5-25. 
Suthar MK, Verma A, Doharey PK, Singh SV, 
Saxena JK. Single tryptophan of disordered loop from 
plasmodium falciparum purine nucleoside phosphory-
lase: involvement in catalysis and microenvironment. 
Appl Biochem Biotechnol. 2013a;170:868-79. 
Suthar MK, Doharey PK, Verma A, Saxena JK. Be-
havior of plasmodium falciparum purine nucleoside 
phosphorylase in macromolecular crowded environ-
ment. Int J Biol Macromol. 2013b;62:657-62. 
Suttiprapa S, Loukas A, Laha T, Wongkham S, 
Kaewkes S, Gaze S, et al. Characterization of the an-
tioxidant enzyme, thioredoxin peroxidase, from the 
carcinogenic human liver fluke, Opisthorchis viver-
rini. Mol Biochem Parasitol. 2008;160:116-22. 
Tian Y, Chen JP, Hu XS. [Cloning and sequence 
analysis of the ribosomal DNA ITS gene of Leishma-
nia donovani isolates from hill foci of China]. 
Zhongguo ji sheng chong xue yu ji sheng chong bing 
za zhi, Chin J Parasitol Parasit Dis. 2004;22:294-6. 
Tsai B, Rodighiero C, Lencer WI, Rapoport TA. Pro-
tein disulfide isomerase acts as a redox-dependent 
chaperone to unfold cholera toxin. Cell. 
2001;104:937-48. 
Verma A, Suthar MK, Doharey PK, Gupta S, Yadav 
S, Chauhan PM, et al. Molecular cloning and charac-
terization of glucose-6-phosphate dehydrogenase 
from Brugia malayi. Parasitology. 2013;140:897-906. 
Verma A, Chandra S, Suthar MK, Doharey PK, Sid-
diqi MI, Saxena JK. NADP+ binding effects trypto-
phan accessibility, folding and stability of recombi-
nant B. malayi G6PD. Int J Biol Macromol. 
2016;85:645-54. 
Wang J, Zhao F, Yu CX, Xiao D, Song LJ, Yin XR, 
et al. Identification of proteins inducing short-lived 
antibody responses from excreted/secretory products 
of Schistosoma japonicum adult worms by immuno-
proteomic analysis. J Proteomics. 2013;87:53-67. 
Wiederstein M, Sippl MJ. ProSA-web: interactive 
web service for the recognition of errors in three-
dimensional structures of proteins. Nucleic Acids Res. 
2007; 35(Suppl 2):W407-10. 
Winter AD, McCormack G, Page AP. Protein disul-
fide isomerase activity is essential for viability and 
extracellular matrix formation in the nematode Cae-
norhabditis elegans. Develop Biol. 2007;308:449-61.  
Yadav S, Gupta S, Selvaraj C, Doharey PK, Verma A, 
Singh SK, et al. In silico and in vitro studies on the 
protein-protein interactions between Brugia malayi 
immunomodulatory protein calreticulin and human 
C1q. PloS One. 2014;9(9):e106413. 
 
